384 related articles for article (PubMed ID: 23168528)
1. Mrp1 is essential for sphingolipid signaling to p-glycoprotein in mouse blood-brain and blood-spinal cord barriers.
Cartwright TA; Campos CR; Cannon RE; Miller DS
J Cereb Blood Flow Metab; 2013 Mar; 33(3):381-8. PubMed ID: 23168528
[TBL] [Abstract][Full Text] [Related]
2. Targeting blood-brain barrier sphingolipid signaling reduces basal P-glycoprotein activity and improves drug delivery to the brain.
Cannon RE; Peart JC; Hawkins BT; Campos CR; Miller DS
Proc Natl Acad Sci U S A; 2012 Sep; 109(39):15930-5. PubMed ID: 22949658
[TBL] [Abstract][Full Text] [Related]
3. Sphingolipid signaling reduces basal P-glycoprotein activity in renal proximal tubule.
Miller DS
J Pharmacol Exp Ther; 2014 Mar; 348(3):459-64. PubMed ID: 24385389
[TBL] [Abstract][Full Text] [Related]
4. The development and maintenance of paclitaxel-induced neuropathic pain require activation of the sphingosine 1-phosphate receptor subtype 1.
Janes K; Little JW; Li C; Bryant L; Chen C; Chen Z; Kamocki K; Doyle T; Snider A; Esposito E; Cuzzocrea S; Bieberich E; Obeid L; Petrache I; Nicol G; Neumann WL; Salvemini D
J Biol Chem; 2014 Jul; 289(30):21082-97. PubMed ID: 24876379
[TBL] [Abstract][Full Text] [Related]
5. The sphingosine 1-phosphate transporter, SPNS2, functions as a transporter of the phosphorylated form of the immunomodulating agent FTY720.
Hisano Y; Kobayashi N; Kawahara A; Yamaguchi A; Nishi T
J Biol Chem; 2011 Jan; 286(3):1758-66. PubMed ID: 21084291
[TBL] [Abstract][Full Text] [Related]
6. Individual variation of human S1P₁ coding sequence leads to heterogeneity in receptor function and drug interactions.
Obinata H; Gutkind S; Stitham J; Okuno T; Yokomizo T; Hwa J; Hla T
J Lipid Res; 2014 Dec; 55(12):2665-75. PubMed ID: 25293589
[TBL] [Abstract][Full Text] [Related]
7. Sphingosine-1-phosphate receptor 1 agonism attenuates lung ischemia-reperfusion injury.
Stone ML; Sharma AK; Zhao Y; Charles EJ; Huerter ME; Johnston WF; Kron IL; Lynch KR; Laubach VE
Am J Physiol Lung Cell Mol Physiol; 2015 Jun; 308(12):L1245-52. PubMed ID: 25910934
[TBL] [Abstract][Full Text] [Related]
8. The neurobiology of sphingosine 1-phosphate signaling and sphingosine 1-phosphate receptor modulators.
Soliven B; Miron V; Chun J
Neurology; 2011 Feb; 76(8 Suppl 3):S9-14. PubMed ID: 21339490
[TBL] [Abstract][Full Text] [Related]
9. Sphingosine 1-phosphate enhances the excitability of rat sensory neurons through activation of sphingosine 1-phosphate receptors 1 and/or 3.
Li C; Li JN; Kays J; Guerrero M; Nicol GD
J Neuroinflammation; 2015 Apr; 12():70. PubMed ID: 25880547
[TBL] [Abstract][Full Text] [Related]
10. Functional characterization of sphingosine 1-phosphate receptor agonist in human endothelial cells.
Butler J; Lana D; Round O; LaMontagne K
Prostaglandins Other Lipid Mediat; 2004 Jan; 73(1-2):29-45. PubMed ID: 15165029
[TBL] [Abstract][Full Text] [Related]
11. S1PR1 (Sphingosine-1-Phosphate Receptor 1) Signaling Regulates Blood Flow and Pressure.
Cantalupo A; Gargiulo A; Dautaj E; Liu C; Zhang Y; Hla T; Di Lorenzo A
Hypertension; 2017 Aug; 70(2):426-434. PubMed ID: 28607130
[TBL] [Abstract][Full Text] [Related]
12. Sphingosine 1 Phosphate at the Blood Brain Barrier: Can the Modulation of S1P Receptor 1 Influence the Response of Endothelial Cells and Astrocytes to Inflammatory Stimuli?
Spampinato SF; Obermeier B; Cotleur A; Love A; Takeshita Y; Sano Y; Kanda T; Ransohoff RM
PLoS One; 2015; 10(7):e0133392. PubMed ID: 26197437
[TBL] [Abstract][Full Text] [Related]
13. Sphingosine-1-phosphate receptor 1 mediates elevated IL-6 signaling to promote chronic inflammation and multitissue damage in sickle cell disease.
Zhao S; Adebiyi MG; Zhang Y; Couturier JP; Fan X; Zhang H; Kellems RE; Lewis DE; Xia Y
FASEB J; 2018 May; 32(5):2855-2865. PubMed ID: 29401601
[TBL] [Abstract][Full Text] [Related]
14. Sphingosine 1-phosphate (S1P): Physiology and the effects of S1P receptor modulation.
Hla T; Brinkmann V
Neurology; 2011 Feb; 76(8 Suppl 3):S3-8. PubMed ID: 21339489
[TBL] [Abstract][Full Text] [Related]
15. [Effects of sphingosine 1-phosphate on functions of T cell - review].
Huang WR; Wang LS; DA WM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Aug; 13(4):718-22. PubMed ID: 16129068
[TBL] [Abstract][Full Text] [Related]
16. FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P1) modulation.
Choi JW; Gardell SE; Herr DR; Rivera R; Lee CW; Noguchi K; Teo ST; Yung YC; Lu M; Kennedy G; Chun J
Proc Natl Acad Sci U S A; 2011 Jan; 108(2):751-6. PubMed ID: 21177428
[TBL] [Abstract][Full Text] [Related]
17. FTY720 stimulates multidrug transporter- and cysteinyl leukotriene-dependent T cell chemotaxis to lymph nodes.
Honig SM; Fu S; Mao X; Yopp A; Gunn MD; Randolph GJ; Bromberg JS
J Clin Invest; 2003 Mar; 111(5):627-37. PubMed ID: 12618517
[TBL] [Abstract][Full Text] [Related]
18. Targeting the SphK1/S1P/S1PR1 Axis That Links Obesity, Chronic Inflammation, and Breast Cancer Metastasis.
Nagahashi M; Yamada A; Katsuta E; Aoyagi T; Huang WC; Terracina KP; Hait NC; Allegood JC; Tsuchida J; Yuza K; Nakajima M; Abe M; Sakimura K; Milstien S; Wakai T; Spiegel S; Takabe K
Cancer Res; 2018 Apr; 78(7):1713-1725. PubMed ID: 29351902
[TBL] [Abstract][Full Text] [Related]
19. [Role of S1P acting both inside and outside the cells].
Okada T; Nakamura S
Seikagaku; 2012 Feb; 84(2):92-101. PubMed ID: 22550899
[No Abstract] [Full Text] [Related]
20. Targeting sphingosine-1-phosphate in hematologic malignancies.
Stevenson CE; Takabe K; Nagahashi M; Milstien S; Spiegel S
Anticancer Agents Med Chem; 2011 Nov; 11(9):794-8. PubMed ID: 21707492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
